投稿信息
投稿信息
审稿周期
投稿命中率
审稿费用
暂无数据
版面费用
暂无数据
中国人发表比例
2023年中国人文章占该期刊总数量暂无数据 (2022年为100.00%)
自引率
2.8 %
年文章数
3146
NCBI查询
偏重的研究方向
期刊简介
稿件收录要求
稿件收录要求
The Journal of Cancer Research and Clinical Oncology contains significant and up-to-date articles within the fields of experimental and clinical oncology.
The Journal, which is chiefly devoted to Original papers and Rapid communications (given priority treatment by the Editors), also includes Reviews as well as Editorials and Guest editorials on current, controversial topics. The section Letters to the editors provides a forum for a rapid exchange of comments and information concerning previously published papers and topics of current interest. Meeting reports provide current information on the latest results presented at important congresses.
The following fields are covered:
Carcinogenesis - etiology, mechanisms · Molecular biology · Recent developments in tumor therapy · General diagnosis · Laboratory diagnosis · Diagnostic and experimental pathology · Oncologic surgery · Epidemiology.
Manuscripts submitted for publication must contain a statement to the effect that all human studies have been examined by the appropriate ethics committee and have therefore been performed in accordance with the ethical standards laid down in the 1964 Declaration of Helsinki. It should also be stated clearly in the text that all persons gave their informed consent prior to their inclusion in the study. Details that might disclose the identity of the subjects under study should be omitted.
Reports of animal experiments must state that the 'Principles of laboratory animal care' (NIH publication No. 85-23, revised 1985) were followed, as well as specific national laws (e.g. the current version of the German Law on the Protection of Animals) where applicable.
The editors reserve the right to reject manuscripts that do not comply with the above-mentioned requirements. The author will be held responsible for false statements or for failure to fulfill the above-mentioned requirements.
The copyright covers the exclusive right and license (for U.S. government employees: to the extent transferable) to reproduce, publish, distribute and archive the article in all forms and media of expression now known or developed in the future, including reprints, translations, photographic reproductions, microform, electronic form (offline, online) or any other reproductions of similar nature.
